Adaptive Biotechnologies Corp (ADPT)
Healthcare
Diagnostics & Research
22.60 $
-6.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Adaptive Biotechnologies Corp (ADPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -46 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -35 | -32 | 205 | -150 | -193 | -184 | -156 | -95 | -46 | |
| 5.8 | 6.0 | 7.8 | 8.5 | 21 | 28 | 22 | 19 | 18 | |
| 7.0 | 11 | 13 | 25 | 43 | 55 | 63 | 54 | 51 | |
| 7.7 | 9.9 | 11 | 25 | 43 | 56 | – | – | – | |
| -5.5 | -1.7 | 255 | -41 | -57 | -72 | -46 | -17 | -58 | |
| 2.5 | 6.3 | 11 | 19 | 62 | 16 | 11 | 3.7 | 3.0 | |
| 36 | 0.7 | -482 | -117 | 181 | 2.9 | 130 | 78 | 38 | |
| 0.0 | 0.0 | – | – | – | – | – | – | – | |
| 50 | 1.3 | 325 | 294 | 27 | 7.9 | – | – | – | |
| 0.0 | 0.0 | – | – | 0.0 | 124 | – | – | – | |
| 50 | 1.2 | 320 | 294 | 27 | 132 | 2.2 | 0.2 | 30 | |
| 52 | -30 | 44 | 27 | 16 | -49 | -25 | -17 | 22 | |
| -37 | -39 | 194 | -168 | -254 | -200 | -167 | -99 | -49 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.